Alpha Signal Monitor - Daily Market Briefing | July 09, 2026
Daily Market Research Report
July 09, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional outlook on Gold ETFs (GLD, IAU, BAR) — As of July 9, 2026
Trading Idea: Buy Rationale (TL;DR): Most top-tier houses still see higher gold into late-2026 despite drawdowns: Goldman Sachs $5,400 end‑2026; UBS $5,900 end‑2026 (with near‑term cut to end‑June); Deutsche Bank $6,000 in 2026; J.P. Morgan cut its 2026 average to $5,243/oz but still flags scope to rally toward $6,000; Morgan Stanley is more moderate at $4,800 by 4Q26. Central‑bank diversification and an eventual easing in real yields underpin the call. (investing.com)
Backdrop: 2025’s surge left positioning stretched; 2026 has seen volatility as the dollar and real yields occasionally firm, but banks still cite robust central‑bank buying, persistent geopolitical risk, and scope for softer real rates later in the cycle. UBS highlights sustained central‑bank demand with a staged path to $5,900 by December 2026; J.P. Morgan notes softer near‑term investor flows (including light ETF demand) behind its average‑price downgrade; HSBC sees risk of a mid‑2026 spike toward $5,000 before a cooler finish; BofA research flags that easing cycles with inflation >2% have historically supported gold. (ubs.com)
Key Drivers - Central‑bank reserve diversification and ongoing official‑sector purchases. - Prospect of lower real rates into 2026–2027 after policy tightness peaks. - Portfolio hedging demand amid fiscal/debt concerns and geopolitical risk. - Intermittent ETF inflows as risk sentiment and rate expectations swing. - US dollar path (potential weakening later would be supportive).
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | End‑2026 forecast: $5,400/oz (raised from $4,900); view reaffirmed Mar 31, 2026. | GS lifted its end‑2026 target to $5,400 on Jan 22, citing private‑sector and EM central‑bank diversification; reiterated the call on Mar 31. (investing.com) | 2026-03-31 | (sahmcapital.com) |
| Morgan Stanley | Positive (moderate) | Q4‑2026: $4,800/oz. | MS forecast $4,800 by 4Q26 on falling rates, Fed leadership change and continued safe‑haven/central‑bank demand. (investing.com) | 2026-01-06 | (investing.com) |
| JP Morgan | Constructive medium‑term; cautious near‑term | 2026 average cut to $5,243/oz (from $5,708), but bank still sees potential rally toward ~$6,000 on renewed demand. | JPM cited softer near‑term investor demand (muted futures and ETF flows) for the downgrade while keeping a medium‑term bullish path. (sahmcapital.com) | 2026-05-18 | (sahmcapital.com) |
| Bank of America | Bullish | 2026: $5,000/oz (with ~${4,400}/oz average). | BofA Global Research lifted its 2026 outlook to $5,000/oz and ~${4,400} average; its 2026 macro themes discuss gold’s resilience when the Fed eases with inflation >2%. (investing.com) | 2025-10-13 | (investing.com) |
| Citigroup | Base case: Neutral to slightly cautious over 12 months; Bull case higher | Near‑term (0–3m) target raised to $5,000 on Jan 13, 2026; bull‑case path: $5,000 by end‑2026 and $6,000 by end‑2027 (podcast). | Reuters factbox recorded Citi’s 0–3m target at $5,000 on Jan 13; Citi’s commodities head outlined a base‑case neutral 12‑month view with a bull case to $5,000 (’26) and $6,000 (’27). (investing.com) | 2026-01-13 | (investing.com) |
| UBS | Positive/Attractive (CIO) | Targets: $5,200 end‑June 2026; $5,400 Sep‑26; $5,900 Dec‑26. | UBS CIO cut the near‑term (end‑June) target to $5,200 amid higher real yields/stronger USD but kept the December 2026 target at $5,900 on structural demand. (ubs.com) | 2026-04-02 | (ubs.com) |
| HSBC | Neutral to cautious for late‑2026; spike risk mid‑year | Sees risk of $5,000/oz in 1H26; trims 2026 average to ~$4,587 and year‑end to ~$4,450. | HSBC highlighted geopolitics/debt as drivers for a 1H26 spike but guided to a cooler average and year‑end profile for 2026. (investing.com) | 2026-01-08 | (investing.com) |
| Deutsche Bank | Bullish | 2026: $6,000/oz (reiterated). | Reuters factbox cited DB reiterating a $6,000/oz 2026 view alongside other banks’ updates. (investing.com) | 2026-02-02 | (investing.com) |
Risk Considerations - Upside surprises in real yields or a persistently strong USD that pressure non‑yielding assets. - A sharp reversal in ETF flows/positioning, triggering drawdowns. - Reduced or delayed policy easing versus expectations. - Central‑bank net selling or a drop in unreported official demand. - De‑escalation of geopolitical risks or faster growth lifting opportunity cost of gold.
Position via GLD, IAU or BAR as core proxies for spot gold; accumulate on weakness while real yields remain the key swing factor. Expect choppy near‑term tape but maintain a pro‑risk skew into late‑2026; reassess sizing if USD strength persists or ETF outflows accelerate.
Stock Ratings — Mega-cap tech: latest targets and ratings from GS/MS/JPM/BAC/C/WFC (as of July 9, 2026)
Below are the most recent publicly reported ratings/targets from the requested institutions per stock. Dates are in YYYY-MM-DD. Targets are 12‑month unless the source specifies otherwise.
AAPL - Apple Inc.
Coverage remains broadly positive; several banks raised targets into mid-2026.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $340 | 2026-05-01 | Raised from $330; analyst: Michael Ng. | https://www.streetinsider.com/Analyst+Comments/Apple+(AAPL)+PT+Raised+to+$340+at+Goldman+Sachs/26411049.html |
| Morgan Stanley | Overweight | $360 | - | Raised from $330 per The Fly summary; analyst: Erik Woodring. | https://www.tipranks.com/news/the-fly/apple-price-target-raised-to-360-from-330-at-morgan-stanley-thefly-news |
| JP Morgan | Overweight | $325 | 2026-01-30 | Raised from $315; analyst: Samik Chatterjee. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Buy | $380 | 2026-06-18 | Reiterated Buy; analyst: Wamsi Mohan. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Citigroup | Buy | - | 2026-06-01 | Reiterated Buy (target not shown on public page). | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Overweight | $310 | 2026-05-01 | Raised from $300; analyst: Aaron Rakers. | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Moderate Buy, Target Price: $314.85 - MarketBeat 35-analyst average and rating.
MSFT - Microsoft Corp.
Targets trimmed in early 2026 on AI capex optics; stance broadly positive.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $600 | 2026-02-23 | Reiterated Buy and $600 PT; analyst: Gabriela Borges. | https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Reiterates+Buy+Rating+on+Microsoft+(MSFT)/26038994.html |
| Morgan Stanley | Overweight | $600 | 2026-01-29 | Lowered from $655; analyst: Gabriela Borges (coverage call echoed across sources). | https://www.streetinsider.com/Analyst+Comments/Microsoft+(MSFT)+PT+Lowered+to+$600+at+Goldman+Sachs/25910721.html |
| JP Morgan | Overweight | $550 | 2025-07-31 | Lowered from $575; latest explicit PT found dated 2025-07-31; rating reiterated 2026-01-29 without public PT. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Outperform | $515 | 2026-03-24 | Lowered from $620; analyst shown on page: Tal Liani (per MarketBeat list). | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Buy / Market Outperform | - | 2026-06-01 | Initiated coverage; public page did not show target. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Overweight | $650 | 2026-06-01 | Raised from $625; analyst: Michael Turrin. | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Moderate Buy, Target Price: $560.98 - MarketBeat 47-analyst average and rating.
GOOGL - Alphabet Inc.
Multiple upward PT revisions post late‑April events; stance broadly bullish.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $450 | 2026-04-30 | Raised from $400. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Overweight | $415 | 2026-06-30 | Raised from $375; analyst: Brian Nowak. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Overweight | $460 | 2026-04-30 | Raised from $395; analyst: Doug Anmuth. | https://www.streetinsider.com/Analyst+Comments/Alphabet+(GOOGL)+PT+Raised+to+$460+at+JPMorgan/26400372.html |
| Bank of America | Buy | - | 2026-05-20 | BofA reiterated Buy around I/O; commonly reported at ~$430 PT, but public doc not fully viewable; leaving PT null. | https://www.streetinsider.com/dr/quote.php?q=GOOGL |
| Citigroup | Buy / Outperform | - | 2026-05-04 | Reiterated Outperform; public page did not show target. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Overweight | $416 | 2026-07-02 | Lowered from $435; analyst: Ken Gawrelski. | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Moderate Buy, Target Price: $413.54 - MarketBeat 54-analyst average and rating.
AMZN - Amazon.com Inc.
Across the Street, targets were broadly raised late April; stance remains constructive.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $325 | 2026-04-30 | Raised from $275. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Morgan Stanley | Overweight | $330 | 2026-04-30 | Raised from $300; analyst: Brian Nowak. | https://www.tipranks.com/news/the-fly/amazon-com-price-target-raised-to-330-from-300-at-morgan-stanley-thefly-news |
| JP Morgan | Overweight | $313 | 2026-06-26 | Small upward tweak from $312; analyst: Doug Anmuth. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | $320 | 2026-04-30 | Raised from $275. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | Market Outperform | $315 | 2026-06-01 | Set target and reiterated Market Outperform; analyst: Ronald Josey. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Overweight | - | 2026-07-02 | Recent update noted on page; target not shown on public view. | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Moderate Buy, Target Price: $312.62 - MarketBeat 60-analyst average and rating.
NVDA - NVIDIA Corp.
Post-earnings (May 2026) saw widespread target lifts; still consensus Buy.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $325 | 2026-05-20 | Reiterated Buy; analyst listed: Kevin Cassidy. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Morgan Stanley | Overweight | $288 | 2026-05-21 | Fine-tuned from $285; analyst: Joseph Moore. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| JP Morgan | Buy | $270 | 2026-05-21 | Raised from $220; analyst: Harlan Sur. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Bank of America | Buy | $350 | 2026-05-21 | Raised from $320; analyst: Vivek Arya. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Citigroup | Buy | - | 2026-04-10 | Initiated Buy; target not shown on public page. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
| Wells Fargo | Overweight | - | 2026-05-12 | Update logged; explicit PT not shown on public page. | https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/ |
Consensus View - Rating: Buy, Target Price: $303.84 - MarketBeat 54-analyst average and rating.
META - Meta Platforms Inc.
Targets were trimmed by some and tweaked by others post-Q1; still broadly positive.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | Listed among recent brokerages; specific public PT line not visible on page snapshot. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Morgan Stanley | Overweight | $775 | 2026-03-18 | Lowered from $825; analyst: Brian Nowak. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| JP Morgan | Overweight | - | 2026-04-30 | Update logged on page; explicit PT not shown on public view; analyst: Doug Anmuth. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Bank of America | Buy | $820 | 2026-04-10 | Lowered from $885; analyst: Justin Post. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Citigroup | Outperform | - | 2026-01-29 | Reiterated Outperform; PT not shown on public page; analyst: Ronald Josey. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
| Wells Fargo | Overweight | $767 | 2026-07-02 | Slight raise from $765; analyst: Ken Gawrelski. | https://www.marketbeat.com/stocks/NASDAQ/META/forecast/ |
Consensus View - Rating: Moderate Buy, Target Price: $840.64 - MarketBeat 48-analyst average and rating.
TSLA - Tesla Inc.
Data from requested institutions not retrieved in this pass.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
AVGO - AVGO Corp.
Data from requested institutions not retrieved in this pass.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
TSM - TSM Corp.
Data from requested institutions not retrieved in this pass.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Highlights
- AAPL: BofA at $380 (Buy) and GS at $340 (Buy); JPM at $325 (OW).
- MSFT: GS at $600 (Buy); MS at $600 (OW); WFC at $650 (OW).
- GOOGL: JPM at $460 (OW); GS at $450 (Buy); MS at $415 (OW); WFC at $416 (OW).
- AMZN: MS at $330 (OW); GS at $325 (Buy); BofA at $320 (Buy); C at $315 (MO).
- NVDA: BofA at $350 (Buy); GS at $325 (Buy); MS at $288 (OW); JPM at $270 (Buy).
- META: WFC nudged PT to $767 (OW); MS trimmed to $775 (OW); BofA to $820 (Buy).
Notes: Where a bank’s public note was paywalled, a high‑quality secondary source (StreetInsider/The Fly via TipRanks/MarketBeat) is referenced. Items marked null indicate that a recent, citable public target/rating was not available from the requested institutions on open sources.
IPO Calendar
Timeframe: July 9, 2026 through August 9, 2026 (U.S. equity markets)
Window opens with one of the year’s largest offerings (SK hynix) alongside sizable infrastructure and energy deals. Themes: (1) AI infrastructure buildout drives capital needs in data centers and semiconductors (Csquare; SK hynix); (2) power and energy security show up via advanced nuclear fuel (Standard Nuclear); (3) small-cap health care and specialized optics continue to trickle (Tarsier; MetaOptics). Deal timing remains fluid week to week; some names are firm-dated while others have terms filed but no set pricing date yet. (renaissancecapital.com)
Tarsier Pharma Ltd. (TARX)
- Expected listing date: 2026-07-09
- Price range: $8.00–$10.00
- Shares offered: 5,000,000
- Exchange: NYSE American
- Lead underwriters: Konik Capital Partners
- Business summary: Israel-based, late-stage biopharmaceutical company developing steroid‑free therapies for inflammatory eye diseases (notably uveitis/uveitic glaucoma) built on its dazdotuftide platform (TRS01 eye drops; TRS02 intravitreal). (renaissancecapital.com)
- Notes: Filed on Form F-1; terms set to 5.0M shares at $8–$10. Calendars show pricing July 8 for a July 9 debut; as with micro-cap health care offerings, timing can slip. (sec.gov)
- Sources: Renaissance Capital profile: Tarsier Pharma (TARX), SEC EDGAR: Tarsier Pharma F‑1/A (June 16, 2026), Benzinga IPO Calendar (as of July 9, 2026), StockAnalysis IPO Calendar (accessed July 9, 2026)
SK hynix Inc. (SKHY)
- Expected listing date: 2026-07-10
- Price range: $158.14 per ADS (as‑converted reference price)
- Shares offered: 177,900,000 ADS
- Exchange: Nasdaq Global Select Market
- Lead underwriters: BofA Securities, Citigroup, Goldman Sachs, J.P. Morgan, Cantor Fitzgerald, Mizuho Securities, Needham & Company, RBC Capital Markets, Rosenblatt Securities, Stifel, Wedbush Securities, William Blair, WR Securities, Nomura Securities
- Business summary: One of the world’s largest memory chipmakers (DRAM, NAND, high‑bandwidth memory); offering U.S. ADRs to broaden investor base and fund capacity tied to AI demand. Plans Nasdaq listing while remaining listed on the KRX. (renaissancecapital.com)
- Notes: Nasdaq Trader indicates when‑issued trading on July 10, 2026 under SKHYV; final offer expected to be set the evening of July 9 before U.S. trading. SEC filings on Form F‑1/A; several calendars show Jul 10 as the first trade date. (nasdaqtrader.com)
- Sources: Renaissance Capital news: SK hynix sets terms (July 6, 2026), Nasdaq Trader Equity Trader Alert #2026‑37 (when‑issued details), SEC EDGAR: SK hynix F‑1/A (July 6, 2026), Axios: SK hynix plans $28B U.S. stock offering (July 8, 2026), StockAnalysis IPO Calendar (accessed July 9, 2026)
Csquare, Inc. (CSQR)
- Expected listing date: 2026-07-16
- Price range: $23.00–$27.00
- Shares offered: 50,000,000
- Exchange: NYSE
- Lead underwriters: Morgan Stanley, TD Securities, Wells Fargo Securities, BofA Securities, BMO Capital Markets, Scotia Capital, Jefferies, J.P. Morgan, RBC Capital Markets, Société Générale
- Business summary: Carrier‑neutral colocation data center operator providing space, power, interconnection and related services across 64 facilities in major U.S. metros (with UK presence); revenue largely recurring, tied to long‑duration, availability‑sensitive workloads. (renaissancecapital.com)
- Notes: Terms: 50M shares at $23–$27; expected to price the week of July 13 with several calendars showing July 16 as the target listing date. Public S‑1/A on July 6 confirms structure and NYSE ticker CSQR. (renaissancecapital.com)
- Sources: Renaissance Capital news: Csquare sets terms (July 6, 2026), Benzinga IPO Calendar (as of July 9, 2026), StockAnalysis IPO Calendar (accessed July 9, 2026), SEC EDGAR: Csquare S‑1/A (July 6, 2026)
Standard Nuclear, Inc. (STDN)
- Price range: $18.00–$21.00
- Shares offered: 18,300,000
- Exchange: NYSE
- Lead underwriters: BofA Securities, Goldman Sachs, Barclays, UBS Investment Bank, Evercore ISI, RBC Capital Markets, William Blair, Stifel
- Business summary: U.S. advanced nuclear fuel manufacturer focused on TRISO fuel for small modular and micro‑reactors; claims industrial‑scale TRISO capability and active shipments for demonstration programs, with plans to expand capacity in 2H26. (renaissancecapital.com)
- Notes: Terms filed July 7, 2026; launch press release indicates NYSE ticker STDN. No firm pricing/trade date yet; expected in the coming weeks, subject to market conditions. Registration on Form S‑1; third‑party calendars reflect size and valuation but not a set date. (streetinsider.com)
- Sources: Renaissance Capital profile: Standard Nuclear (STDN), Company press release via Business Wire/StreetInsider (July 7, 2026), SEC EDGAR: Standard Nuclear S‑1 and subsequent amendments (June–July 2026), Investing.com IPO Calendar (accessed July 9, 2026)
MetaOptics Ltd. (MOT)
- Price range: $5.00–$7.00
- Shares offered: 3,000,000 ADS
- Exchange: Nasdaq
- Lead underwriters: Roth Capital Partners, The Benchmark Company
- Business summary: Singapore‑based designer and manufacturer of ultra‑thin metalens (flat optics) components and camera modules, positioning meta‑optics for next‑gen imaging and IoT applications. (renaissancecapital.com)
- Notes: Filed on Form S‑1 and related depositary documentation; several calendars show placeholder early‑to‑mid July dates, but no confirmed pricing as of July 9, 2026. Treat timing as tentative. (sec.gov)
- Sources: Renaissance Capital profile: MetaOptics (MOT), SEC EDGAR: MetaOptics S‑1 (spring 2026) and Form F‑6 (May 19, 2026), Webull IPO page (accessed July 9, 2026)
Columbus Circle Capital III (SPAC) (CCCTU)
- Price range: $10.00 (unit)
- Shares offered: 20,000,000 units
- Exchange: Nasdaq
- Lead underwriters: Cohen & Company Securities, Clear Street
- Business summary: Blank‑check company sponsored by affiliates of Cohen & Company, targeting AI/digital infrastructure, sports/media, energy transition, mining and crypto. (renaissancecapital.com)
- Notes: Filed terms for a $200 million SPAC IPO; on Renaissance Capital’s weekly calendar but without a firm pricing date as of July 9, 2026. SPAC unit structure may include fractional warrants; confirm final terms at pricing. (renaissancecapital.com)
- Sources: Renaissance Capital profile: Columbus Circle Capital III (CCCTU), Renaissance Capital weekly IPO calendar (accessed July 9, 2026)
Dates, price ranges, and share counts are based on current filings and exchange notices and can change up to pricing; some calendars post estimated dates that later shift. ADR offerings (e.g., SK hynix) may begin with when‑issued trading (SKHYV) before regular‑way settlement. Always confirm final prospectus, pricing wire, and exchange notices before trading. (nasdaqtrader.com)
Sources
- Stock Ratings: https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/META/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.marketbeat.com/stocks/NASDAQ/NVDA/forecast/, https://www.streetinsider.com/Analyst+Comments/Alphabet+(GOOGL, https://www.streetinsider.com/Analyst+Comments/Apple+(AAPL, https://www.streetinsider.com/Analyst+Comments/Goldman+Sachs+Reiterates+Buy+Rating+on+Microsoft+(MSFT, https://www.streetinsider.com/Analyst+Comments/Microsoft+(MSFT, https://www.streetinsider.com/dr/quote.php?q=GOOGL, https://www.tipranks.com/news/the-fly/amazon-com-price-target-raised-to-330-from-300-at-morgan-stanley-thefly-news, https://www.tipranks.com/news/the-fly/apple-price-target-raised-to-360-from-330-at-morgan-stanley-thefly-news
- IPO Calendar: https://www.nasdaqtrader.com/TraderNews.aspx?id=ETA2026-37&utm_source=openai, https://www.renaissancecapital.com/IPO-Center/Calendar, https://www.renaissancecapital.com/IPO-Center/News/120281/Korea-listed-memory-chip-giant-SK-hynix-sets-terms-for-%2428.1-billion-US-IPO, https://www.renaissancecapital.com/IPO-Center/News/120290/Data-center-operator-Csquare-sets-terms-for-%241.3-billion-IPO, https://www.renaissancecapital.com/Profile/CCCTU/Columbus-Circle-III/IPO, https://www.renaissancecapital.com/Profile/MOT/MetaOptics/IPO, https://www.renaissancecapital.com/Profile/STDN/Standard-Nuclear/IPO, https://www.renaissancecapital.com/Profile/TARX/Tarsier-Pharma/IPO, https://www.sec.gov/Archives/edgar/data/2099681/000121390026039821/filename1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2102720/000121390026069143/0001213900-26-069143-index.htm?utm_source=openai, https://www.streetinsider.com/Business%2BWire/Standard%2BNuclear%2BAnnounces%2BLaunch%2Bof%2Bits%2BInitial%2BPublic%2BOffering/26738397.html?utm_source=openai
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-07-09 at 12:23 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI